Eva Wagner

922 total citations
23 papers, 434 citations indexed

About

Eva Wagner is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Eva Wagner has authored 23 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Eva Wagner's work include Listeria monocytogenes in Food Safety (6 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Essential Oils and Antimicrobial Activity (4 papers). Eva Wagner is often cited by papers focused on Listeria monocytogenes in Food Safety (6 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Essential Oils and Antimicrobial Activity (4 papers). Eva Wagner collaborates with scholars based in Germany, United States and Austria. Eva Wagner's co-authors include Kathrin Rychli, Paul Chaplin, Solveig Langsrud, Edgar T. Overton, Josef Weigl, Thomas Meyer, Annette Fagerlund, Trond Møretrø, Garth Virgin and Jack T. Stapleton and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Eva Wagner

23 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Wagner Germany 12 190 151 112 101 73 23 434
John Rothman United States 9 104 0.5× 15 0.1× 125 1.1× 184 1.8× 17 0.2× 13 568
Faı̈za Rharbaoui Germany 11 117 0.6× 21 0.1× 92 0.8× 7 0.1× 16 0.2× 21 471
Rogier Gaiser United States 9 224 1.2× 27 0.2× 253 2.3× 26 0.3× 17 0.2× 12 650
Adel Benlahrech United Kingdom 13 140 0.7× 199 1.3× 128 1.1× 18 0.2× 4 0.1× 34 650
Lisa N. Henning United States 12 193 1.0× 13 0.1× 75 0.7× 36 0.4× 8 0.1× 23 442
F. A. C. van Engelenburg Netherlands 13 87 0.5× 18 0.1× 213 1.9× 13 0.1× 5 0.1× 14 477
Jenni Adamsson Sweden 7 77 0.4× 15 0.1× 55 0.5× 28 0.3× 15 0.2× 10 362
Andres Männik Estonia 14 155 0.8× 84 0.6× 173 1.5× 34 0.3× 30 482
Shannon M. Harrison United States 6 50 0.3× 87 0.6× 203 1.8× 11 0.1× 7 0.1× 7 339

Countries citing papers authored by Eva Wagner

Since Specialization
Citations

This map shows the geographic impact of Eva Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Wagner more than expected).

Fields of papers citing papers by Eva Wagner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Wagner. The network helps show where Eva Wagner may publish in the future.

Co-authorship network of co-authors of Eva Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Wagner. A scholar is included among the top collaborators of Eva Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Wagner. Eva Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Møretrø, Trond, Eva Wagner, Even Heir, Solveig Langsrud, & Annette Fagerlund. (2023). Genomic analysis of Listeria monocytogenes CC7 associated with clinical infections and persistence in the food industry. International Journal of Food Microbiology. 410. 110482–110482. 5 indexed citations
3.
Fagerlund, Annette, Eva Wagner, Trond Møretrø, et al.. (2022). Pervasive Listeria monocytogenes Is Common in the Norwegian Food System and Is Associated with Increased Prevalence of Stress Survival and Resistance Determinants. Applied and Environmental Microbiology. 88(18). e0086122–e0086122. 37 indexed citations
5.
Wagner, Eva, Annette Fagerlund, Sarah Thalguter, et al.. (2022). Deciphering the virulence potential of Listeria monocytogenes in the Norwegian meat and salmon processing industry by combining whole genome sequencing and in vitro data. International Journal of Food Microbiology. 383. 109962–109962. 16 indexed citations
6.
Wagner, Eva, Andreas Zaiser, Narciso M. Quijada, et al.. (2020). Virulence characterization and comparative genomics of Listeria monocytogenes sequence type 155 strains. BMC Genomics. 21(1). 847–847. 31 indexed citations
7.
Socié, Gèrard, Dietger Niederwieser, Nikolas von Bubnoff, et al.. (2020). Biomarker Analysis in Patients (pts) with Steroid-Refractory Acute Graft-Vs-Host Disease (aGVHD) Treated with Ruxolitinib (RUX) or Best Available Therapy (BAT) in the Randomized, Phase 3 REACH2 Study. Blood. 136(Supplement 1). 26–27. 2 indexed citations
8.
Rychli, Kathrin, Eva Wagner, Caitriona M. Guinane, et al.. (2020). Generation of Nonpolar Deletion Mutants in Listeria monocytogenes Using the “SOEing” Method. Methods in molecular biology. 165–175. 2 indexed citations
10.
Gatti‐Mays, Margaret E., Julius Strauss, Renee N. Donahue, et al.. (2019). A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules. Clinical Cancer Research. 25(16). 4933–4944. 45 indexed citations
11.
Rajan, Arun, Jhanelle E. Gray, Siddhartha Devarakonda, et al.. (2019). Phase I trial of CV301 in combination with anti-PD-1 therapy in non-squamous NSCLC. Annals of Oncology. 30. v493–v494. 1 indexed citations
12.
Lassnig, Caroline, et al.. (2019). The Novel Internalins InlP1 and InlP4 and the Internalin-Like Protein InlP3 Enhance the Pathogenicity of Listeria monocytogenes. Frontiers in Microbiology. 10. 1644–1644. 12 indexed citations
13.
Overton, Edgar T., Steven J. Lawrence, Eva Wagner, et al.. (2018). Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial. PLoS ONE. 13(4). e0195897–e0195897. 42 indexed citations
14.
Christopeit, Maximilian, Gerald Wulf, Eva Wagner, et al.. (2018). Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis. European Journal Of Haematology. 101(3). 305–317. 34 indexed citations
15.
Greenberg, Richard N., Christine M. Hay, Jack T. Stapleton, et al.. (2016). A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects. PLoS ONE. 11(6). e0157335–e0157335. 54 indexed citations
18.
Wagner, Eva, et al.. (2015). Proteome Profiling of the Rhodobacter capsulatus Molybdenum Response Reveals a Role of IscN in Nitrogen Fixation by Fe-Nitrogenase. Journal of Bacteriology. 198(4). 633–643. 16 indexed citations
19.
Dass, Martin, Eva Wagner, Bodo Plachter, et al.. (2014). Superior In Vitro Stimulation of Human CD8+ T-Cells by Whole Virus versus Split Virus Influenza Vaccines. PLoS ONE. 9(7). e103392–e103392. 9 indexed citations
20.
Portsmouth, Daniel, Richard Fritz, Brian A. Crowe, et al.. (2014). Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus H5N1 Influenza Vaccine in Chronically Ill and Immunocompromised Patients. Clinical and Vaccine Immunology. 21(6). 867–876. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026